Ask the right evidence questions earlier
Dear Kenneth,
Evidence planning can be the difference between a strong launch and late-stage uncertainty. Yet real-world evidence teams are often brought into development too late, after important decisions on patient populations, endpoints, comparators and value narratives have already been made.
Pharma Ignite is pleased to share an IQVIA Insight Brief on how earlier integrated evidence planning can help teams align stakeholder needs across the development lifecycle.
In the brief, you will learn how earlier RWE planning can help:
- Inform clinical trial design and execution
- Identify evidence needs for regulators, payers, physicians and patients
- Support natural history studies and treatment landscape analysis
- Strengthen market sizing, burden of disease and unmet need insights
- Build more credible value stories for access and adoption
Download the brief to explore how asking the right questions earlier can help improve development and launch readiness.
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).
© 2026 Marketing Masters Hub. All rights reserved.